What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta‐regression of observational studies

Stephanie Mathieson(The University of Sydney), Martin Underwood(University Hospitals Coventry and Warwickshire NHS Trust), Sallie‐Anne Pearson(UNSW Sydney), Graeme Wertheimer(The University of Notre Dame Australia), Rachelle Buchbinder(Institute for Musculoskeletal Health), Andrew J. McLachlan(The University of Sydney), Chung‐Wei Christine Lin(The University of Sydney), Christopher G. Maher(The University of Sydney)
Journal of Internal Medicine
February 25, 2020
10.1111/joim.13026
Cited by 79

Related Papers

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|12k
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
OARSI guidelines for the non-surgical management of knee osteoarthritis
|Osteoarthritis and Cartilage|2014|3.1k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
Low back pain: a call for action
|The Lancet|2018|1.3k